Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,000 shares at $42.19 ($422K) on 2020-01-07, disclosed to the SEC on 2020-01-08.
Open-market sale of $422k ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |